Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.1%

1 terminated out of 32 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results91% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (11)
P 1 (1)
P 2 (2)
P 4 (2)

Trial Status

Completed10
Unknown7
Not Yet Recruiting6
Recruiting4
Active Not Recruiting2
Enrolling By Invitation1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT07567911Not Yet RecruitingPrimary

A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia

NCT07461714Active Not RecruitingPrimary

AI-Driven Accurate Diagnosis of Pathogens in Severe Pneumonia

NCT07308340Not Yet RecruitingPrimary

Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT

NCT03831906Not ApplicableCompleted

Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)

NCT07149909Not ApplicableCompleted

Fiberoptic Bronchoscopy in Severe Ventilator-associated Pneumonia

NCT07112976CompletedPrimary

Lung Response to a Higher PEEP During Severe Pneumonia: a CT Study

NCT07113951Enrolling By InvitationPrimary

Diagnostic Application of AI-ROSE in Severe Pneumonia

NCT06114784RecruitingPrimary

Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study

NCT06936683Not Yet RecruitingPrimary

Herpes Simplex Virus Type 1 Infection/Reactivation of Patients With Severe Pneumonia(the HSV-SP Study)

NCT05143593Not ApplicableNot Yet RecruitingPrimary

Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia

NCT06635733Not ApplicableNot Yet Recruiting

Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania

NCT06538441Active Not RecruitingPrimary

Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia

NCT06533514Not Yet RecruitingPrimary

Rapid Diagnosis of Severe Respiratory Tract Infectious Diseases and Screening of Biomarkers for Stratified Diagnosis

NCT06516601Recruiting

Fulminant Severe CAP - an Observational Study

NCT06514781RecruitingPrimary

The Application of Different Sedation Protocols in ICU Patients With Severe Pneumonia

NCT01068990RecruitingPrimary

Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

NCT04794803Phase 2TerminatedPrimary

Reparixin in COVID-19 Pneumonia - Efficacy and Safety

NCT05663905Phase 4CompletedPrimary

Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients

NCT03870243Not ApplicableCompletedPrimary

Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia

NCT05768204Phase 4UnknownPrimary

Research on the Treatment of Severe Community-acquired Pneumonia in Children

Scroll to load more

Research Network

Activity Timeline